What Is the RSI (Relative Strength Index)?

The Relative Strength Index (RSI) is a momentum oscillator technical indicator that measures the speed and magnitude of recent price changes in a security, ranging from 0 to 100. Developed by J. Welles Wilder Jr. in 1978, RSI helps traders identify overbought and oversold conditions in cannabis stocks and other securities. RSI is calculated using the formula: RSI = 100 - (100 / (1 + RS)), where RS (Relative Strength) equals the average gain of up periods divided by the average loss of down periods over a specified timeframe, typically 14 trading days. Traditionally, RSI readings above 70 indicate overbought conditions, suggesting a potential price decline, while readings below 30 suggest oversold conditions and potential price increases. However, cannabis stocks often exhibit higher volatility than traditional markets, with some analysts adjusting these thresholds to 80/20 for more accurate signals in this sector. For cannabis investors, RSI proves particularly valuable given the industry's volatility. Major cannabis stocks like Tilray (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB) have shown RSI swings from single digits during market crashes to above 90 during euphoric rallies. For example, during the 2021 Reddit-driven cannabis rally, many MSO and LP stocks registered RSI levels exceeding 95 before subsequent corrections. RSI divergence patterns can signal trend reversals in cannabis stocks. Bullish divergence occurs when stock prices make lower lows while RSI makes higher lows, potentially indicating an upcoming rally. Conversely, bearish divergence happens when prices reach higher highs while RSI shows lower highs. Limitations include false signals during strong trending markets and the indicator's lagging nature. Cannabis stocks often experience extended periods above or below traditional RSI thresholds due to sector-specific catalysts like legalization news, earnings surprises, or regulatory changes. *Disclaimer: This information is for educational purposes only and should not be considered investment advice. Cannabis stocks carry significant risks, and past performance does not guarantee future results.*